CCM Duopharma Registers Double Digit Top and Bottom Line Growth in First Quarter 2018
Kuala Lumpur – CCM Duopharma Biotech Berhad (CCM Duopharma) recorded a 10.14 per cent growth in Revenue for the first quarter ended March 31, 2018 to RM133.26 billion from RM120.99 million in the same quarter last year. The Group’s Profit before Tax for the first quarter rose 18.60 per cent to RM13.26 million from RM11.18 million in the same period last year while Profit after Tax jumped 23.54 per cent to RM10.65 million from RM8.62 million in the previous year.